These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10482797

  • 1. 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum.
    Royland JE, Delfani K, Langston JW, Janson AM, Di Monte DA.
    Brain Res; 1999 Aug 21; 839(1):41-8. PubMed ID: 10482797
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
    Muramatsu Y, Kurosaki R, Mikami T, Michimata M, Matsubara M, Imai Y, Kato H, Itoyama Y, Araki T.
    Metab Brain Dis; 2002 Sep 21; 17(3):169-82. PubMed ID: 12322787
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
    Di Monte DA, Royland JE, Anderson A, Castagnoli K, Castagnoli N, Langston JW.
    J Neurochem; 1997 Oct 21; 69(4):1771-3. PubMed ID: 9326308
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    Watanabe H, Muramatsu Y, Kurosaki R, Michimata M, Matsubara M, Imai Y, Araki T.
    Eur Neuropsychopharmacol; 2004 Mar 21; 14(2):93-104. PubMed ID: 15013024
    [Abstract] [Full Text] [Related]

  • 5. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y, Itoyama Y, Araki T.
    Neurol Res; 2002 Oct 21; 24(7):655-62. PubMed ID: 12392201
    [Abstract] [Full Text] [Related]

  • 6. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
    Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T.
    J Neural Transm (Vienna); 2008 Jun 21; 115(6):831-42. PubMed ID: 18235988
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K, Palmer S, Castagnoli N.
    Neurobiology (Bp); 1999 Jun 21; 7(2):135-49. PubMed ID: 10591048
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
    Thomas B, Saravanan KS, Mohanakumar KP.
    Neurochem Int; 2008 May 21; 52(6):990-1001. PubMed ID: 18164516
    [Abstract] [Full Text] [Related]

  • 9. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):4565-71. PubMed ID: 8643444
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P, Langston JW, Di Monte DA.
    J Pharmacol Exp Ther; 1993 Dec 14; 267(3):1515-20. PubMed ID: 8263813
    [Abstract] [Full Text] [Related]

  • 12. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T, Arán VJ, Guillén H.
    Free Radic Res; 2009 Oct 14; 43(10):975-84. PubMed ID: 19669997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
    Watanabe Y, Kato H, Araki T.
    Metab Brain Dis; 2008 Mar 14; 23(1):51-69. PubMed ID: 18030609
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.
    Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF.
    J Neurochem; 1995 Feb 14; 64(2):936-9. PubMed ID: 7530297
    [Abstract] [Full Text] [Related]

  • 17. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Castagnoli K, Palmer S, Anderson A, Bueters T, Castagnoli N.
    Chem Res Toxicol; 1997 Apr 14; 10(4):364-8. PubMed ID: 9114971
    [Abstract] [Full Text] [Related]

  • 18. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
    Samantaray S, Mohanakumar KP.
    Neurosci Lett; 2003 Jul 31; 346(1-2):69-72. PubMed ID: 12850550
    [Abstract] [Full Text] [Related]

  • 19. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 31; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 20. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
    Perez V, Unzeta M.
    Neurochem Int; 2003 Feb 31; 42(3):221-9. PubMed ID: 12427476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.